Skip to main content
. 2017 Nov 16;7(11):e014549. doi: 10.1136/bmjopen-2016-014549

Table 3.

CD4+ lymphocyte ratios in vitreous samples

n Mean SD Difference in average value Effect size: d p Value
D-sarcoidosis 61 87.27 8.28 0.44 0.06 >0.9999
S-sarcoidosis 60 87.71 7.37
D-sarcoidosis 61 87.27 8.28 35.74 2.08 <0.0001
Non-sarcoidosis 16 51.53 26.15
D-sarcoidosis 61 87.27 8.28 39.07 2.85 <0.0001
Viral infection 20 48.20 19.16
D-sarcoidosis 61 87.27 8.28 47.68 3.15 <0.0001
Tumour 34 39.59 22.03
D-sarcoidosis 61 87.27 8.28 14.07 0.96 0.0122
Unknown 43 73.20 21.02
S-sarcoidosis 60 87.71 7.37 36.18 2.16 <0.0001
Non-sarcoidosis 16 51.53 26.15
S-sarcoidosis 60 87.71 7.37 39.51 2.98 <0.0001
Viral infection 20 48.20 19.16
S-sarcoidosis 60 87.71 7.37 48.12 3.27 <0.0001
Tumour 34 39.59 22.03
S-sarcoidosis 60 87.71 7.37 14.51 1.02 0.0083
Unknown 43 73.20 21.02
Non-sarcoidosis 16 51.53 26.15 3.33 0.15 >0.9999
Viral infection 20 48.20 19.16
Non-sarcoidosis 16 51.53 26.15 11.94 0.50 >0.9999
Tumour 34 39.59 22.03
Non-sarcoidosis 16 51.53 26.15 21.67 0.92 0.111
Unknown 43 73.20 21.02
Viral infection 20 48.20 19.16 8.61 0.42 >0.9999
Tumour 34 39.59 22.03
Viral infection 20 48.20 19.16 25.00 1.24 0.0056
Unknown 43 73.20 21.02
Tumour 34 39.59 22.03 33.61 1.56 <0.0001
Unknown 43 73.20 21.02